CASC4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.079000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.194200E-01
Normal-vs-Stage2
5.128800E-01
Normal-vs-Stage3
6.709400E-01
Normal-vs-Stage4
2.077200E-01
Stage1-vs-Stage2
5.999200E-01
Stage1-vs-Stage3
8.106000E-02
Stage1-vs-Stage4
5.329800E-01
Stage2-vs-Stage3
2.252600E-01
Stage2-vs-Stage4
2.965400E-01
Stage3-vs-Stage4
9.410200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.239800E-01
Normal-vs-AfricanAmerican
3.397400E-01
Normal-vs-Asian
7.224800E-01
Caucasian-vs-AfricanAmerican
4.692800E-01
Caucasian-vs-Asian
6.601000E-01
AfricanAmerican-vs-Asian
4.131800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.803800E-01
Normal-vs-Female
4.254200E-01
Male-vs-Female
3.861400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.927800E-01
Normal-vs-Age(41-60Yrs)
2.587800E-01
Normal-vs-Age(61-80Yrs)
6.184000E-01
Normal-vs-Age(81-100Yrs)
9.070600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.968200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.473000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.647000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.175500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.041700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.514400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.675600E-01
Normal-vs-Daily Drinker
7.443200E-01
Normal-vs-Weekly Drinker
7.335800E-01
Normal-vs-Occasional Drinker
3.019600E-01
Normal-vs-Social Drinker
6.718000E-01
Non Drinker-vs-Daily Drinker
9.840600E-01
Non Drinker-vs-Weekly Drinker
9.060600E-01
Non Drinker-vs-Occasional Drinker
1.165580E-01
Non Drinker-vs-Social Drinker
7.620800E-01
Daily Drinker-vs-Weekly Drinker
9.362400E-01
Daily Drinker-vs-Occasional Drinker
2.173800E-01
Daily Drinker-vs-Social Drinker
8.204800E-01
Weekly Drinker-vs-Occasional Drinker
3.196800E-01
Weekly Drinker-vs-Social Drinker
9.004400E-01
Occasional Drinker-vs-Social Drinker
3.798800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.369900E-02
Normal-vs-Grade 2
1.435890E-03
Normal-vs-Grade 3
7.498500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.215600E-01
Grade 1-vs-Grade 3
3.328200E-01
Grade 1-vs-Grade 4
6.369900E-02
Grade 2-vs-Grade 3
7.403200E-01
Grade 2-vs-Grade 4
1.435890E-03
Grade 3-vs-Grade 4
7.498500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.278800E-01
Normal-vs-NonDiabetic
5.103000E-01
Diabetic-vs-NonDiabetic
3.948400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.517200E-01
Normal-vs-NoPancreatitis
5.102200E-01
Pancreatitis-vs-NoPancreatitis
6.845000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.490800E-01
Normal-vs-N1
4.820000E-01
N0-vs-N1
7.442800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.556000E-01
Normal-vs-TP53-NonMutant
5.578800E-01
TP53-Mutant-vs-TP53-NonMutant
2.053600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
